Atlas Trials

Study of Cardiopulmonary Exercise Testing in Women Who Have HER2-Positive Breast Cancer With Mild Cardiotoxicity

Clinical trial NCT05036252 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05036252
Sponsor
Memorial Sloan Kettering Cancer Center
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
Breast CancerHER2-positive Breast CancerHER2-positive Metastatic Breast CancerBreast Cancer Stage IBreast Cancer Stage IIBreast Cancer Stage IIIBreast Cancer Stage IVCardiotoxicity
Start date
2021-08-27
Primary completion
2026-08-27
Enrollment
23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.